Caveolae - An alternative endocytotic pathway for targeted drug delivery

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 21, Issue 2, 2004, Pages 67-95

  Bathori, Gyorgy ^a   Cervenak, Laszlo ^a   Karadi, Istvan ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Caveolae; Caveosomes; Endocytosis; Endoplasmic reticulum; Golgi; Liposomes; Rafts; Targeted delivery

Indexed keywords

CAVEOLIN 1; CLATHRIN; DRUG CARRIER; FOLIC ACID; LIPOPROTEIN; LIPOSOME; ANTIBODY; DRUG; LIGAND; MEMBRANE LIPID; PROTEIN;

ARTICLE; CAVEOLA; CELL MEMBRANE; CELL VACUOLE; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; REVIEW;

ANIMALS; ANTIBODIES; CAVEOLAE; DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; MEMBRANE LIPIDS; PHARMACEUTICAL PREPARATIONS; PROTEIN TRANSPORT; PROTEINS;

EID: 3042696831     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i2.10     Document Type: Article

References (156)

1. Szebeni J, Baranyi L, Savay S, Milosevits J, Bodo M, Bunger R, Alving CR. The interaction of liposomes with the complement system: in vitro and in vivo assays. Methods Enzymol 2003; 373:136-54.
2. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Progr Lipid Res 2003; 42(6):463-78.
3. Szebeni J, Baranyi L, Savay S, Gotze O, Alving CR, Bunger R, Mongan PD. Complement activation during hemorrhagic shock and resuscitation in swine. Shock 2003; 20(4):347-55.
4. Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 2003; 14(9):1430-7.
5. Basta M, Van Goor F, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L, Szebeni J, Alving CR, Carroll MC, Berkower I, Stojilkovic SS, Metcalfe DD. F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003; 9(4):431-8.
6. Szebeni J, Baranyi L, Savay S, Milosevits J, Bunger R, Laverman P, Metselaar JM, Storm G, Chanan-Khan A, Liebes L, Muggia FM, Cohen R, Barenholz Y, Alving CR. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 2002; 12(1-2): 165-72.
7. Savay S, Szebeni J, Baranyi L, Alving CR. Potentiation of liposome-induced complement activation by surface-bound albumin. Biochim Biophys Acta 2002; 1559(1): 79-86.
8. Szebeni J. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents. Crit Rev Ther Drug Carrier Syst 2001; 18(6):567-606.
9. Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, Stahl GL, Bunger R, Alving CR. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol Heart Circ Physiol 2000; 279(3):H1319-28.
10. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, Stahl GL, Bunger R, Alving CR. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 1999; 99(17):2302-9.
11. Szebeni J, Spielberg H, Cliff RO, Wassef NM, Rudolph AS, Alving CR. Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. Artif Cells Blood Substit Immobil Biotechnol 1997; 25(4):347-55.
12. Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep 2002; 22(2): 197-224.
13. Rensen PC, Schiffelers RM, Versluis AJ, Bijsterbosch MK, Van Kuijk-Meuwissen ME, Van Berkel TJ. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Mol Pharmacol 1997; 52(3):445-55.
14. Moghimi SM, Hunter AC. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res 2001; 18(1):1-8.
15. Chonn A, Semple SC, Cullis PR. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 1992; 267(26): 18759-65.
16. Bogers WM, Stad RK, Janssen DJ, Prins FA, van Rooijen N, van Es LA, Daha MR. Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells. Clin Exp Immunol 1991; 85(1):128-36.
17. Moghimi SM, Porter CJ, Muir IS, Illum L, Davis SS. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991; 177(2):861-6.
18. Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G. In vivo applications of PEG liposomes: unexpected observations. Crit Rev Ther Drug Carrier Syst 2001; 18(6):551-66.
19. Wu J, Nantz MH, Zern MA. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci 2002; 7:d717-25.
20. Lechardeur D, Lukacs GL. Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2002; 2(2):183-94.
21. Takagi T, Hashiguchi M, Hiramatsu T, Yamashita F, Takakura Y, Hashida M. Effect of cationic liposomes on intracellular trafficking and efficacy of antisense oligonucleotides in mouse peritoneal macrophages. J Drug Target 2000; 7(5):363-71.
22. Colin M, Maurice M, Trugnan G, Kornprobst M, Harbottle RP, Knight A, Cooper RG, Miller AD, Capeau J, Coutelle C, Brahimi-Horn MC. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther 2000; 7(2):139-52.
23. Spragg DD, Alford DR, Greferath R, Larsen CE, Lee KD, Gurtner GC, Cybulsky MI, Tosi PF, Nicolau C, Gimbrone MA Jr. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci USA 1997; 94(16):8795-800.
24. Schreier H, Moran P, Caras IW. Targeting of liposomes to cells expressing CD4 using glycosylphosphatidylinositol-anchored gp120. Influence of liposome composition on intracellular trafficking. J Biol Chem 1994; 269(12):9090-8.
25. Anderson RG. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 1993; 90(23):10909-13.
26. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422(6927):37-44.
27. Felberbaum-Corti M, Van Der Goot FG, Gruenberg J. Sliding doors: clathrin-coated pits or caveolae? Nat Cell Biol 2003; 5(5):382-4.
28. Gumbleton M, Abulrob AG, Campbell L. Caveolae: an alternative membrane transport compartment. Pharm Res 2000; 17(9):1035-48.
29. Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol 2003; 161(4): 673-7.
30. Nichols BJ, Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol 2001; 11(10):406-12.
31. Norkin LC. Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv Drug Deliv Rev 2001; 49(3):301-15.
32. Pelkmans L, Helenius A. Endocytosis via caveolae. Traffic 2002; 3(5):311-20.
33. Nichols B. Caveosomes and endocytosis of lipid rafts. J Cell Sci 2003; 116(Pt 23): 4707-14.
34. Alonso MA, Millan J. The role of lipid rafts in signaling and membrane trafficking in T lymphocytes. J Cell Sci 2001; 114(Pt 22):3957-65.
35. Bender F, Montoya M, Monardes V, Leyton L, Quest AF. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 2002; 35(2):151-67.
36. Draber P, Draberova L. Lipid rafts in mast cell signaling. Mol Immunol 2002; 38(16-18):1247-52.
37. Fielding CJ. Caveolae and signaling. Curr Opin Lipidol 2001; 12(3):281-7.
38. Hynes TR, Hughes TE, Berlot CH. Cellular localization of GFP-tagged alpha subunits. Methods Mol Biol 2004; 237:233-46.
39. Kanzaki M, Pessin JE. Insulin signaling: GLUT4 vesicles exit via the exocyst. Curr Biol 2003; 13(14):R574-6.
40. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994; 126(1):111-26.
41. Liu J, Shapiro JI. Endocytosis and signal transduction: basic science update. Biol Res Nurs 2003; 5(2):117-28.
42. Massimino ML, Griffoni C, Spisni E, Tone M, Tomasi V. Involvement of caveolae and caveolae-like domains in signaling, cell survival and angiogenesis. Cell Signal 2002; 14(2):93-8.
43. Muller G, Frick W. Signaling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin. Cell Mol Life Sci 1999; 56(11-12):945-70.
44. Ohanian J, Ohanian V. Sphingolipids in mammalian cell signaling. Cell Mol Life Sci 2001; 58(14):2053-68.
45. Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993; 122(4):789-807.
46. Matveev S, Uittenbogaard A, van Der Westhuyzen D, Smart EJ. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 2001; 268(21):5609-16.
47. Uittenbogaard A, Everson WV, Matveev SV, Smart EJ. Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J Biol Chem 2002; 277(7):4925-31.
48. Ikonen E, Parton RG. Caveolins and cellular cholesterol balance. Traffic 2000; 1(3): 212-7.
49. Liu P, Ying Y, Zhao Y, Mundy DI, Zhu M, Anderson RG. Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J Biol Chem 2004; 279(5):3787-92.
50. Schroeder F, Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Huang H, Starodub O, Chao H, Yang H, Frolov A, Kier AB. Recent advances in membrane microdomains: rafts, caveolae, and intracellular cholesterol trafficking. Exp Biol Med (Maywood) 2001; 226(10):873-90.
51. Harris J, Werling D, Hope JC, Taylor G, Howard CJ. Caveolae and caveolin in immune cells: distribution and functions. Trends Immunol 2002; 23(3):158-64.
52. Shin JS, Abraham SN. Caveolae as portals of entry for microbes. Microbes Infect 2001; 3(9):755-61.
53. Shin J-S, Abraham SN. Co-option of endocytic functions of cellular caveolae by pathogens. Immunology 2001; 102(1):2-7.
54. Peng Y, Akmentin W, Connelly MA, Lund-Katz S, Phillips MC, Williams DL. Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol Biol Cell 2004; 15(1):384-96.
55. Mulcahy JV, Riddell DR, Owen JS. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochem J 2004; 377(Pt 3):741-7.
56. Hansen GH, Niels-Christiansen LL, Immerdal L, Danielsen EM. Scavenger receptor class B type I (SR-BI) in pig enterocytes: trafficking from the brush border to lipid droplets during fat absorption. Gut 2003; 52(10):1424-31.
57. Zeng Y, Tao N, Chung KN, Heuser JE, Lublin DM. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem 2003; 278(46):45931-6.
58. Dagher G, Donne N, Klein C, Ferre P, Dugail I. HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes. J Lipid Res 2003; 44(10):1811-20.
59. Malerod L, Juvet K, Gjoen T, Berg T. The expression of scavenger receptor class B, type I (SR-BI) and caveolin-1 in parenchymal and nonparenchymal liver cells. Cell Tiss Res 2002; 307(2):173-80.
60. Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, Shaul PW. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 2001; 7(7):853-7.
61. Graf GA, Matveev SV, Smart EJ. Class B scavenger receptors, caveolae and cholesterol homeostasis. Trends Cardiovasc Med 1999; 9(8):221-5.
62. Urban S, Zieseniss S, Werder M, Hauser H, Budzinski R, Engelmann B. Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells. J Biol Chem 2000; 275(43):33409-15.
63. de Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999; 66(5):740-6.
64. Matveev S, van der Westhuyzen DR, Smart EJ. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 1999; 40(9):1647-54.
65. Reaven E, Lua Y, Nomoto A, Temel R, Williams DL, van der Westhuyzen DR, Azhar S. The selective pathway and a high-density lipoprotein receptor (SR-BI) in ovarian granulosa cells of the mouse. Biochim Biophys Acta 1999; 1436(3):565-76.
66. Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 1997; 389(6651):636-9.
67. Kiss AL, Turi A, Mullner N, Timar J. Caveolin isoforms in resident and elicited rat peritoneal macrophages. Eur J Cell Biol 2000; 79(5):343-9.
68. Kiss AL, Geuze HJ. Caveolae can be alternative endocytotic structures in elicited macrophages. Eur J Cell Biol 1997; 73(1):19-27.
69. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001; 3(5): 473-83.
70. Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 1997; 9(4):534-42.
71. Arni S, Keilbaugh SA, Ostermeyer AG, Brown DA. Association of GAP-43 with detergent-resistant membranes requires two palmitoylated cysteine residues. J Biol Chem 1998; 273(43):28478-85.
72. Stulnig TM, Berger M, Sigmund T, Raederstorff D, Stockinger H, Waldhausl W. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol 1998; 143(3):637-44.
73. Ge M, Field KA, Aneja R, Holowka D, Baird B, Freed JH. Electron spin resonance characterization of liquid ordered phase of detergent-resistant membranes from RBL-2H3 cells. Biophys J 1999; 77(2):925-33.
74. Ostermeyer AG, Beckrich BT, Ivarson KA, Grove KE, Brown DA. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells. Methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. J Biol Chem 1999; 274(48):34459-66.
75. Sharma P, Sabharanjak S, Mayor S. Endocytosis of lipid rafts: an identity crisis. Semin Cell Dev Biol 2002; 13(3):205-14.
76. Palade GE. Fine structure of blood capillaries. J Appl Phys 1953; 24:1424-1436.
77. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68(4):673-82.
78. Vasile E, Simionescu M, Simionescu N. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 1983; 96(6):1677-89.
79. Nistor A, Simionescu M. Uptake of low density lipoproteins by the hamster lung. Interactions with capillary endothelium. Am Rev Respir Dis 1986; 134(6):1266-72.
80. Snelting-Havinga I, Mommaas M, Van Hinsbergh VW, Daha MR, Daems WT, Vermeer BJ. Immunoelectron microscopic visualization of the transcytosis of low density lipoproteins in perfused rat arteries. Eur J Cell Biol 1989; 48(1):27-36.
81. Simionescu M, Simionescu N. Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev 1991; 25(1):5-78.
82. Irie S, Tavassoli M. Transendothelial transport of macromolecules: the concept of tissue-blood barriers. Cell Biol Rev 1991; 25(4):317-33, 340-1.
83. Alexander JJ, Miguel R, Graham D. Low density lipoprotein uptake by an endothelial-smooth muscle cell bilayer. J Vasc Surg 1991; 13(3):444-51.
84. Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RG, Lacey SW. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc Natl Acad Sci USA 1992; 89(13):6006-9.
85. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255(5043):410-1.
86. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 1992; 118(5):1003-14.
87. Glenney JR Jr. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett 1992; 314(1):45-8.
88. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, DeGunzburg J, Mumby SM, Gilman AG, Anderson RG. Purification and characterization of smooth muscle cell caveolae. J Cell Biol 1994; 126(1):127-38.
89. Lisanti MP, Tang ZL, Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol 1993; 123(3):595-604.
90. Lisanti MP, Tang Z, Scherer PE, Sargiacomo M. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol 1995; 250:655-68.
91. Gonzalez-Gaitan M, Stenmark H. Endocytosis and signaling: a relationship under development. Cell 2003; 115(5):513-21.
92. Deckert M, Ticchioni M, Bernard A. Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J Cell Biol 1996; 133(4):791-9.
93. Lobie PE, Sadir R, Graichen R, Mertani HC, Morel G. Caveolar internalization of growth hormone. Exp Cell Res 1999; 246(1):47-55.
94. Incardona JP, Eaton S. Cholesterol in signal transduction. Curr Opin Cell Biol 2000; 12(2):193-203.
95. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1(1):31-9.
96. Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992; 68(3): 533-44.
97. van Meer G, Simons K. Viruses budding from either the apical or the basolateral plasma membrane domain of MDCK cells have unique phospholipid compositions. Embo J 1982; 1(7):847-52.
98. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988; 27(17): 6197-202.
99. van Meer G, Stelzer EH, Wijnaendts-van-Resandt RW, Simons K. Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells. J Cell Biol 1987; 105(4): 1623-35.
100. van Meer G, Simons K. Lipid polarity and sorting in epithelial cells. J Cell Biochem 1988; 36(1):51-8.
101. Simons K, Dupree P, Fiedler K, Huber LA, Kobayashi T, Kurzchalia T, Olkkonen V, Pimplikar S, Parton R, Dotti C. Biogenesis of cell-surface polarity in epithelial cells and neurons. Cold Spring Harb Symp Quant Biol 1992; 57:611-9.
102. Dupree P, Parton RG, Raposo G, Kurzchalia TV, Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells. Embo J 1993; 12(4):1597-605.
103. Fiedler K, Kobayashi T, Kurzchalia TV, Simons K. Glycosphingolipid- enriched, detergent-insoluble complexes in protein sorting in epithelial cells. Biochemistry 1993; 32(25):6365-73.
104. Sprenger RR, Speijer D, Back JW, De Koster CG, Pannekoek H, Horrevoets AJ. Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 2004; 25(1): 156-72.
105. Foster LJ, De Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 2003; 100(10): 5813-8.
106. Bini L, Pacini S, Liberatori S, Valensin S, Pellegrini M, Raggiaschi R, Pallini V, Baldari CT. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem J 2003; 369(Pt 2):301-9.
107. Nebl T, Pestonjamasp KN, Leszyk JD, Crowley JL, Oh SW, Luna EJ. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J Biol Chem 2002; 277(45):43399-409.
108. Cullis PR, Chonn A, Semple SC. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv Drug Deliv Rev 1998; 32(1-2):3-17.
109. Oja CD, Semple SC, Chonn A, Cullis PR. Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta 1996; 1281(1):31-7.
110. Semple SC, Chonn A, Cullis PR. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 1996; 35(8):2521-5.
111. Chonn A, Semple SC, Cullis PR. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem 1995; 270(43):25845-9.
112. Bathori G, Parolini I, Tombola F, Szabo I, Messina A, Oliva M, De Pinto V, Lisanti M, Sargiacomo M, Zoratti M. Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains. J Biol Chem 1999; 274(42): 29607-12.
113. Bahamonde MI, Fernandez-Fernandez JM, Guix FX, Vazquez E, Valverde MA. Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl-currents in C1300 neuroblastoma cells. J Biol Chem 2003; 278(35):33284-9.
114. Bahamonde MI, Valverde MA. Voltage-dependent anion channel localises to the plasma membrane and peripheral but not perinuclear mitochondria. Pflugers Arch 2003; 446(3):309-13.
115. Gonzalez-Gronow M, Kalfa T, Johnson CE, Gawdi G, Pizzo SV. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem 2003; 278(29):27312-8.
116. McGeoch JE, Palmer DN. Ion pores made of mitochondrial ATP synthase subunit c in the neuronal plasma membrane and Batten disease. Mol Genet Metab 1999; 66(4): 387-92.
117. Brown RE. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J Cell Sci 1998; 111(Pt 1):1-9.
118. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E. Lipid rafts reconstituted in model membranes. Biophys J 2001; 80(3):1417-28.
119. Yuan C, Johnston LJ. Distribution of ganglioside GM1 in L-alpha-dipalmitoylphosp hatidylcholine/cholesterol monolayers: a model for lipid rafts. Biophys J 2000; 79(5): 2768-81.
120. Yuan C, Johnston LJ. Atomic force microscopy studies of ganglioside GM1 domains in phosphatidylcholine and phosphatidylcholine/cholesterol bilayers. Biophys J 2001; 81(2):1059-69.
121. Veatch SL, Keller SL. A closer look at the canonical "Raft Mixture" in model membrane studies. Biophys J 2003; 84(1):725-6.
122. Milhiet PE, Giocondi MC, Le Grimellec C. AFM Imaging of lipid domains in model membranes. Scientif World J 2003; 3(3):59-74.
123. Scherfeld D, Kahya N, Schwille P. Lipid dynamics and domain formation in model membranes composed of ternary mixtures of unsaturated and saturated phosphatidylcholines and cholesterol. Biophys J 2003; 85(6):3758-68.
124. Li XM, Momsen MM, Brockman HL, Brown RE. Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes. Biophys J 2003; 85(6):3788-801.
125. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32:257-83.
126. Pike LJ, Miller JM. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem 1998; 273(35):22298-304.
127. Gulbins E. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 2003; 47(5):393-9.
128. Zhou X, Turecek F, Scott CR, Gelb MH. Quantification of cellular acid sphingomyelinase and galactocerebroside beta-galactosidase activities by electrospray ionization mass spectrometry. Clin Chem 2001; 47(5):874-81.
129. Grassme H, Cremesti A, Kolesnick R, Gulbins E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 2003; 22(35):5457-70.
130. Mundy DI, Machleidt T, Ying YS, Anderson RG, Bloom GS. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J Cell Sci 2002; 115(Pt 22):4327-39.
131. Schnitzer JE, Liu J, Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995; 270(24):14399-404.
132. Upla P, Marjomaki V, Kankaanpaa P, Ivaska J, Hyypia T, Van Der Goot FG, Heino J. Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol Biol Cell 2004; 15(2):625-36.
133. Sabharanjak S, Sharma P, Parton RG, Mayor S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2002; 2(4):411-23.
134. Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, Dautry-Varsat A. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 2001; 7(3):661-71.
135. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141(4):905-15.
136. Parton RG. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994; 42(2):155-66.
137. Torgersen ML, Skretting G, van Deurs B, Sandvig K. Internalization of cholera toxin by different endoqtic mechanisms. J Cell Sci 2001; 114(Pt 20):3737-47.
138. Shogomori H, Futerman AH. Cholera toxin is found in detergent-insoluble rafts/ domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 2001; 276(12):9182-8.
139. Abrami L, Liu S, Cosson P, Leppla SH, van der Goot FG. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 2003; 160(3):321-8.
140. Zuhorn IS, Kalicharan R, Hoekstra D. Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J Biol Chem 2002; 277(20):18021-8.
141. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2003; 377(1):159-69.
142. Uhles S, Moede T, Leibiger B, Berggren PO, Leibiger IB. Isoform-specific insulin receptor signaling involves different plasma membrane domains. J Cell Biol 2003; 163(6):1327-37.
143. Le PU, Nabi IR. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci 2003; 116(Pt 6):1059-71.
144. Bendayan M, Rasio EA. Transport of insulin and albumin by the microvascular endothelium of the rete mirabile. J Cell Sci 1996; 109(Pt 7):1857-64.
145. Kartenbeck J, Stukenbrok H, Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 1989; 109(6 Pt 1):2721-9.
146. Parton RG, Lindsay M. Exploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40. Immunol Rev 1999; 168:23-31.
147. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J Virol 2002; 76(10):5156-66.
148. Sun J, Liao JK. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci USA 2002; 99(20):13108-13.
149. Li WT, Liu P, Pilcher BK, Anderson RG. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 2001; 114(Pt 7): 1397-408.
150. Uittenbogaard A, Ying Y, Smart EJ. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J Biol Chem 1998; 273(11):6525-32.
151. Dermietzel R, Hwang TK, Buettner R, Hofer A, Dotzler E, Kremer M, Deutzmann R, Thinnes FP, Fishman GI, Spray DC, et al. Cloning and in situ localization of a brain-derived porin that constitutes a large-conductance anion channel in astrocytic plasma membranes. Proc Natl Acad Sci USA 1994; 91(2):499-503.
152. Guibert B, Dermietzel R, Siemen D. Large conductance channel in plasma membranes of astrocytic cells is functionally related to mitochondrial VDAC-channels. Int J Biochem Cell Biol 1998; 30(3):379-91.
153. Holton OD 3rd, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN. Biodistribution of monoclonal IgG1, F(ab′)2, and Fab′ in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies. J Immunol 1987; 139(9):3041-9.
154. Weinstein JN, Eger RR, Covell DG, Black CD, Mulshine J, Carrasquillo JA, Larson SM, Keenan AM. The pharmacology of monoclonal antibodies. Ann NY Acad Sci 1987; 507:199-210.
155. McIntosh DP, Tan XY, Oh P, Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 2002; 99(4):1996-2001.
156. Schnitzer JE. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001; 49(3): 265-80.